TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today reported financial results for the first quarter ...

Nuvation Bio Inc. (NYSE: NUVB), a global oncology company tackling some of the toughest challenges in cancer treatment, today reported financial results for the first quarter ended March 31, 2025, and ...

How much does your professional bio matter? Turns out, quite a bit. When people secure legal services, they are investing in ...

Malek Elsayyid is UD's first student to complete the Lerner College's Generative AI for Business graduate certificate program ...

The relative valuations conducted in this article suggest that Cytek presents an undervaluation in the range of 16.43% to 109 ...

Legend Biotech faces a 60% stock drop amid safety, supply issues, and competition for its CAR-T therapy, Carvykti. See here ...